Lantech.com, LLC v. Wulftec International Inc., 2018 FC 41
Jurisdiction | Federal Jurisdiction (Canada) |
Court | Federal Court (Canada) |
Citation | 2018 FC 41 |
Date | 16 January 2018 |
-
- This document is available in original version only for vLex customers
View this document and try vLex for 7 days - TRY VLEX
- This document is available in original version only for vLex customers
3 practice notes
-
Post-AstraZeneca: Has The Promise Doctrine Vanished From Patent Litigation? Likely, Yes
...of California v. I-MED Pharma Inc, 2018 FC 164; Sernova Corp v. Shapiro, 2018 ONSC 841; Lantech.com, LLC v. Wulftec International Inc, 2018 FC 41; Apotex Inc v. AstraZeneca Canada Inc, 2018 FC 181; Hospira Healthcare Corp v. Kennedy Trust for Rheumatology Research, 2018 FC 3 Apotex Inc. v. ......
-
Update: The Promise Doctrine And Utility Post Astrazeneca
...cells which was "a more islet friendly environment" as claimed. [Emphasis Added] Lantech.com, LLC v. Wulftec International Inc, 2018 FC 41 On a motion to re-amend a Statement of Defence and Counterclaim, the Court rejected the Plaintiff's new allegations of inutility grounded in the promise......
-
Specialized Desanders Inc. v. Enercorp Sand Solutions Inc., 2018 FC 689
...pleads sufficient material facts to make out the prior disclosure defence. Referencing Lantech.com, LLC v Wulftec International Inc, 2018 FC 41 [Lantech], the Prothonotary states (in the impugned sentence emphasized above) that no supporting material facts are pleaded as to what information......
1 cases
-
Specialized Desanders Inc. v. Enercorp Sand Solutions Inc., 2018 FC 689
...pleads sufficient material facts to make out the prior disclosure defence. Referencing Lantech.com, LLC v Wulftec International Inc, 2018 FC 41 [Lantech], the Prothonotary states (in the impugned sentence emphasized above) that no supporting material facts are pleaded as to what information......
2 firm's commentaries
-
Post-AstraZeneca: Has The Promise Doctrine Vanished From Patent Litigation? Likely, Yes
...of California v. I-MED Pharma Inc, 2018 FC 164; Sernova Corp v. Shapiro, 2018 ONSC 841; Lantech.com, LLC v. Wulftec International Inc, 2018 FC 41; Apotex Inc v. AstraZeneca Canada Inc, 2018 FC 181; Hospira Healthcare Corp v. Kennedy Trust for Rheumatology Research, 2018 FC 3 Apotex Inc. v. ......
-
Update: The Promise Doctrine And Utility Post Astrazeneca
...cells which was "a more islet friendly environment" as claimed. [Emphasis Added] Lantech.com, LLC v. Wulftec International Inc, 2018 FC 41 On a motion to re-amend a Statement of Defence and Counterclaim, the Court rejected the Plaintiff's new allegations of inutility grounded in the promise......